18.07.2019
- Pharmaceutical market buzz last month had it that private equity investors in Europe and the US were lining up to buy the animal health business Bayer is preparing for sale to pare...
30.04.2019
- Eli Lilly is collaborating with Avidity Biosciences to discover, develop and commercialize potential new medicines in immunology and other select indications. The companies will...
08.04.2019
- The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...
06.03.2019
- Under the name Insulin Lispro, US drugmaker Eli Lilly plans to sell a generic version of its rapid-acting insulin Humalog. It will be priced 50% below the name-brand product, which...
09.01.2019
- In the latest move by “big pharma” to buy into cancer-focused biotechs, US drugmaker Eli Lilly is acquiring Loxo Oncology for about $8 billion in cash. The plans were announced on...
02.11.2018
- Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to...
02.10.2018
- Eli Lilly has entered into an agreement with Chugai Pharmaceutical for the Japanese drugmaker’s oral non-peptidic GLP-1 receptor agonist OWL833, which is currently being developed...
29.07.2018
- Eli Lilly has announced plans to spin off its Elanco animal health business, ending months of uncertainty. The US drugmaker said it will file a registration in the coming weeks...
